Gara Jalqabaatti › Darmaatiitisiis
Qorannoo klinikaalii Darmaatiitisiis Ameerikaa Keessatti hirmaatuu
Qorannoo 7 Darmaatiitisiis f bakka adda addaa Ameerikaa Keessatti hirmaatuu jiru.
Magaalota qorannoo baay'ee qaban
Naannoon
- AlabamaQorannoo 4
- ArkansasQorannoo 3
- CaliforniaQorannoo 6
- FloridaQorannoo 5
- New YorkQorannoo 3
- South CarolinaQorannoo 3
- TexasQorannoo 5
Qorannoo yeroo dhihootti haaromfaman
Takkalaa qorannoo (Ingiliffa)
Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 100 · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT06947993Effects of Treatments on Atopic Dermatitis
Namoota walitti qabaa jiraSadarkaa 2Hojjettoota fayyaa simatamoo
Umuriin 2 hanga 50 · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT01631617A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 6 hanga 11 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06807268First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
Namoota walitti qabaa jiraSadarkaa 1Hojjettoota fayyaa simatamoo
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07527923A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 04-Ful-2026 · NCT07765888A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 28-Hag-2026 · NCT07599813A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 74 · Saalaa hunda · Haaromfame 12-Hag-2026 · NCT07037901Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.